page_banner

MMXIX-nCoV S-RBD Neutralizing Antibody Test Kit (colloidale aurum modum)

MMXIX-nCoV S-RBD Neutralizing Antibody Test Kit (colloidale aurum modum)

Description:

Commodum

Fas

Vaga usus


Product Detail

PICTURAE

Download

Product Tags

Introductio

Nunc omnes vaccini candidati in evolutione clinica MMXIX-nCoV administrantur ab injectione intramusculari.Vaccinatio intramuscularis vel intradermal ad validam inductionem serum Igg
Plus quam 180 candidati vaccini, pluribus diversis suggestis innixi nunc in evolutione contra 2019-nCoV sunt.
S interdum maior est scopo corrumpendi elementorum;
Multi ex his elementis corrumpendis RBD of S interdum oppugnant.

Quomodo iudicare efficientiam 2019-nCoV vaccine?--- Neutralizing Antibody Test Kit

Commodum

Pre probatio vaccini
Candidati ante vaccinationem possunt deprehendere ad anticorpus RBD neutralisandum determinare utrum vaccinatio necessaria sit;

Most vaccina teguntur
Deprehendere potest corrumpendi elementorum quae a plerisque vaccinis in foro producta sunt;

Ieiunium et opportunum
Operatio simplex est, nullo instrumento detecto opus est, eventus intra 15 minutas obtineri potest.

Lepidium sativum munus
Distinguendum est neutralizans anticorpus 2019-nCoV productum ab 2019-nCoV vaccinum vel anticorpus ab 2019-nCoV infectio quaedam vaccina producta, ut vector Viralis (Non-replicating) vaccinum, RNA basi vaccinum et interdum subunitum vaccinum ;

Totum sanguinem test
Totus sanguis expertus operationem commodiorem facit;

Locum applicationis

Pre vaccination
Utrum novis coronavirus infecti fuerint et an vaccinated adhuc opus sit;

Vaccination tempus
Determinare an efficax novum anticorpus neutralising producatur;

Nuper scaena inoculationis
Iuxta epidemiam aream 2019-nCoV, suadet deprehendere exsistentiam MMXIX-nCoV corrumpere anticorpum regulariter singulis tribus mensibus.

Components

Components Pelagus Rebus Quantitas loading (specification)
1 T/Kit 20 T/Kit 50 T/Kit
Test card Testi habena continens colloidal aurum intitulatum anti-humanum IgG anticorpus, aurum colloidale intitulatum anti-galli IgY antibody, 2019-nCoV S-RBD dapibus recombinantibus, Pullus IgY antibody 1 pc* 20 pcs 50 at pede
Sample diluent 0.01M Phosphas solutionis quiddam, 0.5% Twen-20 0.5mL 5mL 10mL

Euismod

Hecin tenui Serum virus neutralization clinicae test Totalis
Positivum Negative
Positivum Positivum 84 9
Negative Negative 8 198
Totalis Totalis 92 207
Fusce sensus Fusce sensus 84/92 91.30% (95%CI: 83.58%~96.17%)
Fusce specificity Fusce specificity 198/207 95.65% (95%CI: 91.91%~97.99%)
Sagacitas Sagacitas 282/299 94.31% (95%CI: 91.05%~96.65%)

 Hecin gerens euismod contra methodum comparatorem in speciminibus seri/plasma.

Hecin tenui Serum virus neutralization clinicae test Totalis
Positivum Negative
Positivum 84 8 92
Negative 8 199 207
Totalis 92 207 299
Fusce sensus 84/92 91.30% (95%CI: 83.58%~96.17%)
Fusce specificity 199/207 96.14% (95%CI: 92.53%~98.32%)
Sagacitas 283/299 94.65% (95%CI: 91.46%~96.91%)

Hecin gerens euismod contra Comparatorem Methodi speciminum integrorum sanguinis.

Test De modo procedendi

Test De modo procedendi-2
Test De modo procedendi

Registration Certificatorium

S-RBD-CEPage3
CE-IVDD DOC MMXIX-nCoV S-RBD Neutralizing Antibody -signed(1)
IVDD DOC MMXIX-nCoV S-RBD Neutralizing Antibody -signed

  • Priora:
  • Deinde:

  • JT08- 1T

    1T9 1T1 1T2 1T3 1T4 1T5 1T6 1T7 1T8

     

     

    JT08- 5T

    5T10 5T1 5T2 5T3 5T4 5T5 5T6 5T7 5T8 5T9

     

     

    JT08- 50T

    50T5 50T1 50T2 50T3 50T4

    Epistulam tuam hic scribe et mitte nobis